Correlation Between ImmuCell and Poniard Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ImmuCell and Poniard Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmuCell and Poniard Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ImmuCell and Poniard Pharmaceuticals, you can compare the effects of market volatilities on ImmuCell and Poniard Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmuCell with a short position of Poniard Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmuCell and Poniard Pharmaceuticals.

Diversification Opportunities for ImmuCell and Poniard Pharmaceuticals

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between ImmuCell and Poniard is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ImmuCell and Poniard Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Poniard Pharmaceuticals and ImmuCell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmuCell are associated (or correlated) with Poniard Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Poniard Pharmaceuticals has no effect on the direction of ImmuCell i.e., ImmuCell and Poniard Pharmaceuticals go up and down completely randomly.

Pair Corralation between ImmuCell and Poniard Pharmaceuticals

If you would invest  358.00  in ImmuCell on September 2, 2024 and sell it today you would earn a total of  54.00  from holding ImmuCell or generate 15.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy4.76%
ValuesDaily Returns

ImmuCell  vs.  Poniard Pharmaceuticals

 Performance 
       Timeline  
ImmuCell 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in ImmuCell are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile fundamental indicators, ImmuCell may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Poniard Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Poniard Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Poniard Pharmaceuticals is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

ImmuCell and Poniard Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ImmuCell and Poniard Pharmaceuticals

The main advantage of trading using opposite ImmuCell and Poniard Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmuCell position performs unexpectedly, Poniard Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Poniard Pharmaceuticals will offset losses from the drop in Poniard Pharmaceuticals' long position.
The idea behind ImmuCell and Poniard Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
CEOs Directory
Screen CEOs from public companies around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum